Betterise Health Tech

Betterise Health Tech represents a mature, certified digital therapeutic company (founded 2013, CE Class IIa, ISO 13485) with solid verified revenue (€2M in 2019) and clinical adoption (80+ establishments). The project demonstrates high Real-World Utility and Technical Innovation due to its regulatory status and impact on Oncology/Cardiology patient outcomes. However, the submission itself ('MysticHeart') contains low-quality, exaggerated form data (e.g., audience 'everyone', traction 'most people have used my product') which contradicts the professional nature of the underlying business. This discrepancy significantly lowers the Response Quality and Traction credibility scores, despite the company's objective success. The score reflects a 'Comparable scale' to the benchmark: established and profitable, but lacking the detailed current growth evidence to push into the higher tier.